Invention Grant
- Patent Title: Use of methylation inhibitors for the treatment of autoimmune diseases
-
Application No.: US17050526Application Date: 2019-04-26
-
Publication No.: US11992500B2Publication Date: 2024-05-28
- Inventor: Tibor A. Rauch , Daniel M. Toth , Tibor T. Glant
- Applicant: Rush University Medical Center
- Applicant Address: US IL Chicago
- Assignee: RUSH UNIVERSITY MEDICAL CENTER
- Current Assignee: RUSH UNIVERSITY MEDICAL CENTER
- Current Assignee Address: US IL Chicago
- Agency: Barnes & Thornburg LLP
- International Application: PCT/US2019/029381 2019.04.26
- International Announcement: WO2019/210192A 2019.10.31
- Date entered country: 2020-10-26
- Main IPC: A61K31/7068
- IPC: A61K31/7068 ; A61K31/353 ; A61K31/4035 ; A61K31/4045 ; A61K31/496 ; A61K31/548 ; A61P19/02 ; A61K45/06
Abstract:
Described herein is a method for treating an autoimmune disease in a patient including administering to the patient in need thereof, a pharmaceutically effective amount of an epigenetic enzyme inhibitor.
Public/Granted literature
- US20210128600A1 Use of Methylation Inhibitors for the Treatment of Autoimmune Diseases Public/Granted day:2021-05-06
Information query
IPC分类:
